X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Indrayani Biotech Ltd.
BSE CODE: 526445   |   NSE CODE: NA   |   ISIN CODE : INE007C01021   |   27-Sep-2024 12:36 Hrs IST
BSE NSE
Rs. 40.79
-0.02 ( -0.05% )
 
Prev Close ( Rs.)
40.81
Open ( Rs.)
40.15
 
High ( Rs.)
41.64
Low ( Rs.)
39.20
 
Volume
30517
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)0.32  1.48  1.23  -3.18  -0.56  
   CEPS(Rs)0.64  1.75  1.34  -3.06  -0.56  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)11.07  11.79  7.06  5.83  -2.36  
   Tax Rate(%)51.57  0.44  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)9.31  11.71  10.76  -22.22  -30.83  
   EBIT Margin(%)12.79  10.64  10.55  -42.45  -30.83  
   Pre Tax Margin(%)4.83  6.82  7.29  -51.82  -40.96  
   PAT Margin (%)2.34  6.79  7.29  -51.82  -40.96  
   Cash Profit Margin (%)4.66  8.04  7.88  -49.91  -40.96  
Performance Ratios          
   ROA(%)1.29  6.75  9.47  -54.34  -181.70  
   ROE(%)3.21  15.67  19.15  -114.06  0.00  
   ROCE(%)7.99  12.45  16.03  -50.65  0.00  
   Asset Turnover(x)0.55  0.99  1.30  1.05  4.44  
   Sales/Fixed Asset(x)2.38  3.42  3.45  1.27  0  
   Working Capital/Sales(x)3.12  4.58  -124.20  -7.79  -2.97  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.42  0.29  0.29  0.79  0.00  
   Receivable days99.04  71.31  55.53  42.09  55.93  
   Inventory Days11.09  7.91  7.71  18.83  0.00  
   Payable days22.26  35.25  45.36  44.01  142.13  
Valuation Parameters          
   PER(x)153.63  38.25  24.70  0.00  0.00  
   PCE(x)77.07  32.29  22.84  -2.07  -14.80  
   Price/Book(x)4.44  4.79  4.32  1.09  -3.53  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)4.53  3.19  2.06  1.74  7.27  
   EV/Core EBITDA(x)29.96  25.35  18.53  -8.30  -23.59  
   EV/EBIT(x)35.40  29.93  19.57  -4.10  -23.59  
   EV/CE(x)2.50  2.75  2.42  0.92  16.54  
   M Cap / Sales3.59  2.60  1.80  1.03  6.06  
Growth Ratio          
   Net Sales Growth(%)-16.32  28.44  176.04  4086.31  0  
   Core EBITDA Growth(%)0.63  44.89  246.66  -2747.04  -188.73  
   EBIT Growth(%)0.55  29.63  168.59  -5663.44  -188.73  
   PAT Growth(%)-71.18  19.67  138.81  -5197.06  -281.12  
   EPS Growth(%)-78.34  19.67  138.82  -463.93  -281.10  
Financial Stability Ratios          
   Total Debt/Equity(x)1.16  0.71  0.69  0.77  -0.80  
   Current Ratio(x)1.39  1.49  0.97  0.77  0.57  
   Quick Ratio(x)1.35  1.44  0.90  0.68  0.57  
   Interest Cover(x)1.61  2.78  3.24  -4.53  -3.05  
   Total Debt/Mcap(x)0.26  0.18  0.16  0.71  0.23